Three Times Weekly Symptom Screening for Children With Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-18
SponsorThe Hospital for Sick Children

About this trial

This study will evaluate the feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks. SPARK is a web-based application that promotes symptom screening for children receiving cancer therapies and enables access to clinical practice guidelines for symptom management. Newly diagnosed and relapsed patients with cancer will be enrolled. Children and/or their guardian will be prompted to complete symptom screening three times weekly via SPARK with corresponding feedback sent to their healthcare providers with each completed assessment. Symptom reports will contain links to clinical practice guidelines for symptom management. Active intervention will last for 8 weeks starting from the date of enrollment.

Eligibility criteria

Qualifiers

cancer diagnosis

2-18 years of age at enrollment

Child has received or a plan for any chemotherapy, radiotherapy or surgery

Understands English, French or Spanish

Disqualifiers

Cognitive disability

Visual impairment (cannot see SPARK even with corrective lens)

Trial design

Treatments tested in this trial

  • SPARK

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators